Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.55% to 10365.44, DAX +0.94% to 24721.46, CAC40 +0.43% to 8273.84, STOXX 600 +0.90% to 617.15

Feb 06 ,2026

  • Synopsis:

    • European indices ended in positive territory, near the session's highs, In macro-news, German exports surged 4.0% m/m in Dec versus consensus of 1.0% and 2.7% in Dec 2024, signaling robust external demand. Instead, industrial production fell 1.9% m/m, missing the -0.3% forecast and reversing Nov's revised +0.2% gain, highlighting sector volatility with key drags from autos (-8.9%) and machinery (-6.8%). Analysts note Dec data halts brief three-month upswing but is viewed as temporary. Exports boosted by China (+10.7%) and UK (+14.6%), while production saw energy-intensive branches -0.9% (implying muted input costs). Strong exports follow yesterday's strong factory orders data which remains on the longest positive run since post-2020 lockdowns. May signal positive momentum for corporate earnings in export-heavy sectors, though production miss tempers near-term upside. Taken together, signals may point to a cyclical upswing in 2026, ending prior stagnation. However, analysts flag deep structural issues like bureaucracy, demographics and taxes which demand reforms under Chancellor Merz for sustainable growth. In the UK, average house prices crossed £300,000 for the first time in Jan, reaching £300,077 according to Halifax-up 0.7% monthly and 1.1% annually

    • On the reporting front, bank names in focus, with SocGen, Banco BPM and Sabadell posting their latest Q4/FY numbers; in Italy, Enel reported prelim FY whilst shares in Stellantis are halted after posting a H2 net loss of (€19B)-(€21B); company also suspended dividends. In the Nordics, Ørsted Kongsberg, Aker Solutions and Coloplast were among several names from the region to issue their most recent numbers before the open. Elsewhere, VINCI SA, Renk Group and Bechtle also updated investors

    • Looking ahead to next week calendars (pls see our StreetAccount Summary - Europe Week Ahead attached below), Ahold Delhaize (AD.NA), Anheuser-Busch InBev (ABI.BB), AstraZeneca (AZN.LN), bp (BP.LN), Barclays (BARC.LN), Hermes (RMS.FP), Michelin (ML.FP), Siemens (SIE.GR), TotalEnergies (TTE.FP) and Unilever (ULVR.LN) will be among several other names updating investors. Key macro-updates will include Eurozone Q4 GDP (2nd est.), UK Q4 preliminary GDP and Dec industrial/manufacturing production

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers: Construct & Mtls +3.50%, Oil & Gas +1.54%, Banks +1.41%, Technology +1.23%, Ind Goods & Svcs +1.15%, Basic Resources +1.15%

      • Underperformers: Autos & Parts (3.00%), Chemicals (0.45%), Food & Beverage +0.00%, Telecom +0.32%, Health Care +0.34%, Financial Svcs +0.37%, Persnl & HHold Goods +0.39%, Real Estate +0.48%, Insurance +0.51%, Media +0.54%, Retail +0.74%, Travel & Leisure +0.85%, Utilities +0.89%

    • Macro:

      • Euro zone ministers to weigh euro-stablecoins, more joint debt issuance to boost role of euro, economic security (Reuters)

      • This by-election in suburbia is Keir Starmer's next nightmare (Politico)

      • Europe threatens to shun British goods just as Starmer embraces Brussels (Telegraph)

      • How "remigration" is penetrating Europe's political mainstream (Economist)

      • Bitcoin falls below $65,000 to wipe out 'Trump rally'(FT)

      • Novo's Stratospheric Rise Has Turned Into a $460 Billion Wipeout (BBG)

      • Western values foundation of future to build together, PM Meloni tells VP Vance (Ansa)

      • Norway Launches Probe Into Former Premier Over Epstein Links (BBG)

    • Company news:

      • Notable Gainers

        • +33.3% MVIR.SS (Medivir SEK0.58, +0.14) -- carries out a directed share issue of SEK 45M to Carl Bennet AB

        • +17.9% HOFI.SS (Hoist Finance SEK141.50, +21.60) -- Q4 earnings

        • +15.6% KOG.NO (Kongsberg Gruppen NOK371.50, +50.05) -- Q4 earnings

        • +15.1% LEHN.SW (LEM Holding CHF329.50, +43.00) -- Q3 earnings

        • +14.7% VIT.B.SS (Vitec Software Group SEK258.20, +33.20) -- Q4 earnings

        • +13.4% KNOW.SS (Knowit SEK124.60, +14.80) -- Q4 earnings

        • +12.4% LINDEX.FH (Lindex Group €2.62, +0.29) -- Q4 earnings

        • +11.4% APAM.NA (Aperam €41.42, +4.24) -- Q4 earnings

        • +10.9% LAGR.B.SS (Lagercrantz Group SEK221.20, +21.70) -- Q3 earnings

        • +10.2% DURC.B.SS (Duroc SEK18.30, +1.70) -- Q2 eanrings; agrees to acquire four companies for SEK121M on a cash- and debt-free basis

        • +9.9% DG.FP (VINCI SA €133.95, +12.10) -- FY eanrings

        • +9.6% MCAP.SS (MedCap SEK542.00, +47.50) -- Q4 earnings

        • +9.2% AKSO.NO (Aker Solutions NOK38.00, +3.20) -- Q4 earnings

        • +8.5% BOOZT.SS (Boozt Fashion SEK96.75, +7.65) -- Q4 earnings

        • +7.4% IBT.B.SS (Infant Bacterial Therapeutics SEK49.95, +3.45) -- Q4 earnings

        • +7.2% TEL.NO (Telenor NOK173.50, +11.60) -- Q4 earnings

        • +5.5% FGR.FP (Eiffage €134.45, +7.05)

        • +5.3% PNDORA.DC (Pandora DKK570.00, +28.80)

        • +4.8% MT.NA (ArcelorMittal €51.34, +2.33)

        • +4.4% DIGIA.FH (Digia €6.64, +0.28) -- Q4 earnings

        • +4.2% CLAS.B.SS (Clas Ohlson SEK329.20, +13.40) -- Jan sales

        • +3.8% VONN.SW (Vontobel Holding CHF67.60, +2.50) -- FY eanrings

        • +3.6% FLS.DC (FLSmidth & Co. DKK591.50, +20.50) -- prelim Q4 earnings

        • +3.5% ORSTED.DC (Ørsted DKK144.20, +4.85) -- Q4 earnings

        • +2.8% SAAB.B.SS (Saab SEK658.10, +17.60)

        • +2.3% FBK.IM (FinecoBank €22.46, +0.50) -- Q4 eanrings

        • +1.8% ASAI.LN (ASA International Group £2.28, +0.04)

        • +1.8% KDEV.SS (Karolinska Development SEK0.26, -0.00) -- portfolio company SVF Vaccines and Novakand Pharma enter into a reverse acquisition agreement

        • +1.2% IQE.LN (IQE £0.08, -0.00)

        • +0.4% BEIA.B.SS (Beijer Alma SEK271.50, +1.00) -- Q4 earnings

      • Notable Decliners

        • -26.3% CTT.SS (CTT Systems SEK121.00, -42.60) -- Q4 earnings

        • -24.0% STLAM.IM (Stellantis €6.17, -1.96) -- H2 earnings; sells its 49% equity stake in NextStar Energy to LG Energy Solution

        • -12.8% HUM.SS (Humana AB SEK43.65, -6.35) -- Q4 earnings

        • -9.4% BC8.GR (Bechtle €38.06, -3.94) -- prelim FY eanrings

        • -8.6% VALMT.FH (Valmet €27.40, -2.57) -- Q4 earnings

        • -8.2% COLO.B.DC (Coloplast DKK493.50, -43.90) -- Q1 eanrings

        • -8.0% TROAX.SS (Troax Group SEK103.60, -9.00)

        • -7.0% XVIVO.SS (Xvivo Perfusion SEK201.40, -15.20)

        • -6.9% ANDR.AV (Andritz €70.75, -5.20) -- prelim FY eanrings

        • -6.9% AYV.FP (Ayvens €11.51, -0.85) -- FY earnings

        • -5.6% YIT.FH (Yit €2.99, -0.18) -- clarifies the reporting of its strategy-aligned business operations; Q4 earnings

        • -5.5% KNEBV.FH (Kone €59.92, -3.52) -- Q4 earnings

        • -4.8% SAB.SM (Banco de Sabadell €3.11, -0.16) -- appoints new CEO; Q4 earnings

        • -4.5% DUNI.SS (Duni SEK101.20, -4.80) -- Q4 earnings

        • -3.9% REL.LN (RELX £21.56, -0.88)

        • -3.9% VCT.LN (Victrex £6.67, -0.27) -- Q1 trading update

        • -3.8% BN.FP (Danone €69.12, -2.76)

        • -3.1% RNO.FP (Renault €30.97, -0.98) -- Stellantis sympathy

        • -3.0% FUTR.LN (Future Plc £4.67, -0.14)

        • -2.6% SKA.B.SS (Skanska SEK272.00, -7.20) -- Q4 earnings

        • -2.5% CAP.FP (Capgemini €114.65, -2.95)

        • -1.9% GLE.FP (Societe Generale €73.20, -1.44) -- Q4 eanrings

        • -1.7% DEDI.SS (Dedicare SEK40.80, -0.70) -- Q4 earnings

        • -1.7% KNOS.LN (Kainos Group £7.57, -0.13)

        • -1.4% EMSN.SW (EMS-Chemie Holding CHF617.00, -8.50) -- FY earnings

        • -1.4% VLA.FP (Valneva €4.02, -0.06) -- Stellantis sympathy

        • -1.2% VOW3.GR (Volkswagen €100.75, -1.25) -- Stellantis sympathy

        • -0.7% AML.LN (Aston Martin Lagonda Global Holdings £0.60, -0.00) -- Stellantis sympathy

        • -0.7% FRVIA.FP (Forvia €14.06, -0.10) -- Stellantis sympathy

        • -0.4% FR.FP (Valeo SE €12.59, -0.04) -- Stellantis sympathy

        • -0.2% METSB.FH (Metsa Board €2.96, -0.01)

    • EU companies reporting on Monday:

      • Benelux: NX Filtration (NXFIL.NA)

      • Nordics: Sagax (SAGA.B.SS), Bakkafrost (BAKKA.NO)

      • Southern Europe: Banca Monte dei Paschi di Siena (BMPS.IM)

      • UK: Plus500 (PLUS.LN), Porvair (PRV.LN), Wynnstay Group (WYN.LN)

      • Trading Update:

        • DACHs: Aumovio (AMV0.GR)

        • France: Beneteau (BEN.FP)

      • CMD/Events: Roche Holding (ROG.SW) Fenebrutinib vs. Ocrevus Phase III FENtrepid study update call

    • Macro-data releases expected on Monday:

      • Switzerland Jan consumer confidence - SECO

      • Norway Q4 GDP, Jan PPI

      • Denmark Dec trade balance

      • Eurozone Feb Sentix economic index

  • Data:

    • Economics:

      • Germany Dec

        • Trade Balance €17.1B vs consensus €14.1B and prior €13.1B

        • Industrial Production (1.9%) m/m vs consensus (0.3%) and prior revised +0.2% from +0.8%

      • UK Jan Halifax House Prices +1.0% y/y vs consensus 0.0% and prior revised +0.4% from +0.3%

      • France Dec Trade Balance (€4.8B) vs consensus (€3.8B) and prior revised (€4.0B) from (€4.2B)

      • Spain Dec Industrial Production (0.3%) y/y vs consensus +4.0% and prior revised +4.6% from +4.5%

      • Switzerland Jan Unemployment Rate (sa) 2.9% vs consensus 3.0% and prior 3.0%

      • Dec Manufacturing Production

        • Denmark (1.0%) m/m vs consensus +4.5% and prior revised (5.8%) from (5.7%)

        • Norway (sa) (0.1%) m/m vs prior revised to +2.0% from +2.4%

      • Sweden Jan preliminary CPI +0.4% y/y vs consensus +0.6% and prior +0.3%

    • Markets:

      • WTI Crude (Mar 26): +$0.75 or +1.19% to $64.04

      • €-$ +0.0038 or +0.32% to 1.1817

      • £-$ +0.0082 or +0.61% to 1.3612

      • €-£ (0.0024) to 0.8683

      • S&P 500 +1.49%

      • Performance year-to-date

        • FTSE 100: +4.37%

        • DAX: +0.94%

        • CAC: +1.53%

        • MIB: +2.08%

        • Stoxx 600: +4.21%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE